Table 1 Baseline characteristics of participants
Group | Control | SA | UA | AMI | P |
|---|---|---|---|---|---|
N | 103 | 190 | 293 | 195 | |
Age (years) | 60.57 ± 9.57 | 62.77 ± 10.68 | 64.70 ± 10.83 | 61.79 ± 11.84 | 0.002 |
Male (%) | 67(65.0) | 154 (81.1) | 225(76.8) | 159(81.5) | 0.006 |
Family history (%) | 8(7.8) | 12 (6.3) | 12(4.1) | 6(3.1) | 0.216 |
Smoking (%) | 25(24.3) | 73 (38.4) | 105(35.8) | 87(44.6) | 0.006 |
Hypertension (%) | 67(65.0) | 108 (56.8) | 191(65.2) | 103(52.8) | 0.025 |
Diabetes mellitus (%) | 24(23.3) | 61 (32.1) | 93(31.7) | 60(30.8) | 0.396 |
FBG (mmol/L)* | 5.41 (3.78-13.64) | 5.64 (5.06-6.94) | 5.74(4.97-7.49) | 5.85(4.92-8.22) | 0.148 |
HbA1c (%) | 6.33 ± 1.59 | 6.50 ± 1.37 | 6.44 ± 1.25 | 6.48 ± 1.38 | 0.727 |
Lp(a)(mmol/L)* | 96.05 (27.06-158.56) | 130.15 (66.79-293.25) | 172.97(82.43-420.94) | 176.97(101.09-289.26) | < 0.001 |
TC(mmol/L) | 4.54 ± 1.07 | 4.29 ± 1.01 | 4.41 ± 1.22 | 4.43 ± 1.08 | 0.316 |
TG(mmol/L) | 1.74 ± 1.40 | 1.59 ± 0.97 | 1.60 ± 0.95 | 1.64 ± 1.13 | 0.792 |
LDL-C (mmol/L) | 2.72 ± 0.89 | 2.57 ± 0.86 | 2.67 ± 0.98 | 2.79 ± 0.91 | 0.263 |
HDL-C (mmol/L) | 1.08 ± 0.26 | 1.02 ± 0.27 | 1.00 ± 0.25 | 0.90 ± 0.17 | < 0.001 |
apoA(mmol/L) | 1.18 ± 0.24 | 1.14 ± 0.32 | 1.10 ± 0.25 | 0.98 ± 0.20 | < 0.001 |
apoB(mmol/L) | 0.81 ± 0.18 | 0.77 ± 0.19 | 0.80 ± 0.22 | 0.85 ± 0.28 | 0.071 |
Lp-PLA2 (μg/L)* | 7.37 (2.34-15.78) | 5.94(2.89-8.55) | 8.56(5.34-11.95) | 8.68(5.56-13.27) | < 0.001 |